Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

727 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial.
Yoshida K, Kodera Y, Kochi M, Ichikawa W, Kakeji Y, Sano T, Nagao N, Takahashi M, Takagane A, Watanabe T, Kaji M, Okitsu H, Nomura T, Matsui T, Yoshikawa T, Matsuyama J, Yamada M, Ito S, Takeuchi M, Fujii M. Yoshida K, et al. Among authors: kakeji y. J Clin Oncol. 2019 May 20;37(15):1296-1304. doi: 10.1200/JCO.18.01138. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925125 Free PMC article. Clinical Trial.
[Chemotherapy for gastric cancer].
Baba H, Kakeji Y, Oki E, Tokunaga E, Ushiro S, Watanabe M, Maehara Y. Baba H, et al. Among authors: kakeji y. Gan To Kagaku Ryoho. 2003 Nov;30(12):1881-8. Gan To Kagaku Ryoho. 2003. PMID: 14650954 Review. Japanese.
[A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):].
Oki E, Kakeji Y, Yoshida R, Ikeda K, Nishida K, Koga T, Egashira A, Tokunaga E, Morita M, Baba H, Maehara Y. Oki E, et al. Among authors: kakeji y. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:138-43. Gan To Kagaku Ryoho. 2006. PMID: 16897990 Clinical Trial. Japanese.
A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer.
Nishikawa K, Morita S, Matsui T, Kobayashi M, Takeuchi Y, Takahashi I, Sato S, Miyashita Y, Tsuburaya A, Sakamoto J, Kakeji Y, Baba H. Nishikawa K, et al. Among authors: kakeji y. Gastric Cancer. 2012 Oct;15(4):363-9. doi: 10.1007/s10120-011-0124-3. Epub 2012 Jan 26. Gastric Cancer. 2012. PMID: 22278377 Clinical Trial.
Phase II trial of alternating mFOLFOX6 and FOLFIRI regimens in the first-line treatment for unresectable or metastatic colorectal cancer (KSCC0701).
Oki E, Emi Y, Akagi Y, Tokunaga S, Sadanaga N, Tanaka T, Ogata Y, Saeki H, Kakeji Y, Baba H, Nishimaki T, Natsugoe S, Shirouzu K, Maehara Y; Kyushu Study Group of Clinical Cancer. Oki E, et al. Among authors: kakeji y. Oncology. 2013;84(4):233-9. doi: 10.1159/000346690. Epub 2013 Jan 31. Oncology. 2013. PMID: 23392220 Clinical Trial.
Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer.
Ishiguro M, Kotake K, Nishimura G, Tomita N, Ichikawa W, Takahashi K, Watanabe T, Furuhata T, Kondo K, Mori M, Kakeji Y, Kanazawa A, Kobayashi M, Okajima M, Hyodo I, Miyakoda K, Sugihara K. Ishiguro M, et al. Among authors: kakeji y. BMC Cancer. 2013 Mar 25;13:149. doi: 10.1186/1471-2407-13-149. BMC Cancer. 2013. PMID: 23530572 Free PMC article.
727 results